Buy Rating for Axsome Therapeutics Driven by Symbravo Approval and Strategic Market Approach
Analyst Ami Fadia of Needham maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), retaining the price target of ...
Gentex Reports Fourth Quarter and Year End 2024 Financial Results
Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass and fire protection technologies, today reported financial results for the fourth quarter and ...
Civil rights activists call for a Target boycott after retailer backs away from diversity programs
Civil rights activists have gathered outside Target's Minneapolis headquarters to call for a boycott of the retailing giant ...